Latest Regulatory News

G8 Education reported a 3.7% revenue decline but a 12.4% rise in net profit for the first half of 2025, amid ongoing cost-of-living challenges impacting occupancy. The company declared a dividend and announced a share buyback, underscoring confidence despite sector headwinds.

G8 Education Limited reported a moderate earnings improvement for the half year ended June 2025 despite ongoing occupancy challenges and regulatory uncertainty. The company is intensifying child safety measures following a Victorian incident and plans a share buy-back to enhance shareholder value.

G8 Education Limited reported a 12.4% rise in net profit to $22.5 million for the first half of 2025, navigating lower occupancy and divestments with strategic cost controls and capital management.

Australian Clinical Labs reported a 6.4% revenue increase and an 8.7% rise in underlying EBIT for FY25, maintaining disciplined growth and operational efficiency in a complex healthcare environment.

Felix Group Holdings has launched a $1 million Share Purchase Plan offering shares at a 3.7% discount to support its acquisition of Nexvia Pty Ltd and growth initiatives.

Fortescue Metals Group reported a robust FY25 with record iron ore shipments and strong profits, while advancing its green metal and decarbonisation initiatives. The company also provided solid FY26 guidance amid ongoing exploration and capital discipline.

29Metals has successfully moved its application for a new tailings storage facility at Capricorn Copper into detailed assessment, marking a critical step toward restarting operations sustainably.

Fortescue Ltd reported a solid FY25 with record iron ore shipments and a strong profit, while making significant strides in its decarbonisation agenda including renewable energy projects and green metal production.

29Metals Limited has reversed a significant loss to report a $35.3 million net profit for the first half of 2025, driven by stronger production at Golden Grove and improved metal prices, while Capricorn Copper remains suspended amid ongoing water and regulatory challenges.

Holista Colltech has inked a binding supply and development agreement with US-based Regenerex Pharma to exclusively supply proprietary ovine collagen for advanced wound care products, targeting the lucrative US market initially with plans for global expansion.

Acusensus Limited reported a robust FY25 with 20% revenue growth and a significant 84% jump in total contract value, setting the stage for an ambitious FY26 forecast of up to 41% revenue increase.

Firebrick Pharma has secured an exclusive licensing agreement with Innorini Pte Ltd to distribute Nasodine products across Singapore, Malaysia, Brunei, and Mauritius, aiming to reduce marketing expenses and broaden market access.